Skip to content

Comparison of pain reduction between 5 and 10 mg of triamcinolone injection in De Quervain syndrome

Comparison of pain reduction between 5 and 10 mg of triamcinolone injection in De Quervains syndrome: a prospective randomized controlled trial

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20221126002
Enrollment
52
Registered
2022-11-26
Start date
2022-11-28
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain and limit activity daily life are the most often complaints of patient with De Quervains syndrome De Quervains syndrome Steroid injection

Interventions

using of corticosteroid by use drug name triamcinolone in dose 5 mg for injection to lesion ,using of corticosteroid by use drug name triamcinolone in dose 10 mg for injection to lesion
Active Comparator Drug,Active Comparator Drug
injection of triamcinolone 5 mg,injection of triamcinolone 10 mg

Sponsors

Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Diagnosis De Quervains syndrome By History of pain at radial styloid side and Physical examination found that swelling, tender, crepitus and Finkelsteins test positive. Decide to treat with non surgical method.

Exclusion criteria

Exclusion criteria: History of allergy to corticosteroid or lidocaine History of surgery tendon Abnormal anatomical structure History of using steroid injection in 1 year History of wrist fructure

Design outcomes

Primary

MeasureTime frame
result of pain treatment 12 weeks visual analog scale

Secondary

MeasureTime frame
Function of hand using after treatment 12 weeks Thai PRWHE score,Side effect of treatment 12 weeks Skin hypotrophy , skin hypo pigment , tendon rupture

Countries

Thailand

Contacts

Public ContactSorawit Denprechawong

Faculty of Medicine Chiang Mai University

sorawitcmu@gmail.com66918392798

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026